This Week at FDA: Bardoxalone strikes out at adcomm; Updated device consensus standards
Regulatory NewsMichael Mezher • Kari Oakes
BiologicsCombination ProductsMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyRegulatory NewsMichael Mezher • Kari OakesBiologicsCombination ProductsMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy